- Home
- CISO vs LTRN Comparison
CISO vs LTRN Comparison
Compare CISO & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- LTRN
- Stock Information
- Founded
- CISO 2015
- LTRN 2013
- Country
- CISO United States
- LTRN United States
- Employees
- CISO 402
- LTRN 21
- Industry
- CISO Computer Software: Prepackaged Software
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- CISO Technology
- LTRN Health Care
- Exchange
- CISO Nasdaq
- LTRN Nasdaq
- Market Cap
- CISO 12.4M
- LTRN 46.7M
- IPO Year
- CISO N/A
- LTRN 2020
- Fundamental
- Price
- CISO $1.05
- LTRN $4.33
- Analyst Decision
- CISO
- LTRN Hold
- Analyst Count
- CISO 0
- LTRN 1
- Target Price
- CISO N/A
- LTRN N/A
- AVG Volume (30 Days)
- CISO 151.1K
- LTRN 167.8K
- Earning Date
- CISO 04-15-2025
- LTRN 03-17-2025
- Dividend Yield
- CISO N/A
- LTRN N/A
- EPS Growth
- CISO N/A
- LTRN N/A
- EPS
- CISO N/A
- LTRN N/A
- Revenue
- CISO $54,633,909.00
- LTRN N/A
- Revenue This Year
- CISO $78.76
- LTRN N/A
- Revenue Next Year
- CISO N/A
- LTRN N/A
- P/E Ratio
- CISO N/A
- LTRN N/A
- Revenue Growth
- CISO 34.87
- LTRN N/A
- 52 Week Low
- CISO $0.26
- LTRN $2.79
- 52 Week High
- CISO $3.84
- LTRN $11.99
- Technical
- Relative Strength Index (RSI)
- CISO 44.67
- LTRN 46.51
- Support Level
- CISO $0.98
- LTRN $4.15
- Resistance Level
- CISO $1.15
- LTRN $4.79
- Average True Range (ATR)
- CISO 0.11
- LTRN 0.45
- MACD
- CISO 0.04
- LTRN -0.11
- Stochastic Oscillator
- CISO 24.90
- LTRN 11.50
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.